Prosperity Consulting Group, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1910398 OWINGS MILLS, MD

Position in ALNY

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$344,435

-$69,518 QoQ

Shares Held

1,041

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Prosperity Consulting Group, LLC holds $912,351 across 5 Biotechnology names. ALNY ranks #1 (37.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,041	$344,435
2	REGN	Regeneron Pharmaceuticals, Inc.	360	$278,150
3	VRTX	Vertex Pharmaceuticals Inc / Ma	558	$249,169
4	BDTX	Black Diamond Therapeutics, Inc.	11,355	$24,186
5	ENLV	Enlivex Ltd.	17,647	$16,411

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$344,435	1,041	0.0%	Shares	Sole	2026-05-05
2025-12-31	$413,953	1,041	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.